4.7 Article

Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections

Journal

FASEB JOURNAL
Volume 26, Issue 3, Pages 1001-1008

Publisher

FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.11-193557

Keywords

asthma; rhinovirus infection

Funding

  1. Austrian Science Fund (FWF) [DK-W1212-B13, F1805, F1818]
  2. Biomay (Vienna, Austria)
  3. Christian Doppler Research Association (Austria)
  4. European Commission [260895]
  5. Austrian Science Fund (FWF) [W1212] Funding Source: Austrian Science Fund (FWF)

Ask authors/readers for more resources

Rhinoviruses (RVs) are the primary cause of upper respiratory tract infections, generally known as the common cold. Moreover, RV infections can trigger severe exacerbations of asthma and chronic obstructive pulmonary disease (COPD). We expressed the 4 major RV capsid proteins, VP1-VP4, in Escherichia coli and used these proteins as well as recombinant and synthetic VP1 fragments to study and map antibody responses in RV-infected humans. VP1, which on infection binds to ICAM 1, was identified as a major target for the memory immune response, residing in the IgG1 subclass and IgA class. Interestingly, this response was mainly directed against an N-terminal 20mer peptide in VP1, P1a, which becomes exposed on intact RV only when it docks to its receptor ICAM 1. Molecular modeling using the 3-dimensional RV capsid structures revealed that P1a was localized inside the capsid and outside the areas involved in receptor binding or RV neutralization. Our results suggest misdirection of antibody responses against a nonprotective epitope as a mechanism how RV escapes immunity and causes recurrent infections. Based on these findings, it may be possible to design vaccines against RV infections and RV-induced respiratory diseases.-Niespodziana, K., Napora, K., Cabauatan, C., Focke-Tejkl, M., Keller, W., Niederberger, V., Tsolia, M., Christodoulou, I., Papadopoulos, N. G., Valenta, R. Misdirected antibody responses against an N-terminal epitope on human RV VP1 as explanation for recurrent RV infections. FASEB J. 26, 1001-1008 (2012). www.fasebj.org

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available